Standout Papers

Use of the Inactivated In... 2004 2026 2011 2018 2004 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation benchmark for papers published in the same subfield and year, or reaches the top citation threshold in at least one of its specific research topics.

  1. Use of the Inactivated Intranasal Influenza Vaccine and the Risk of Bell's Palsy in Switzerland
    2004 694 citations Margot Mütsch, Weigong Zhou et al. New England Journal of Medicine profile →

Immediate Impact

3 by Nobel laureates 7 from Science/Nature 69 hit
Sub-graph 1 of 23

Citing Papers

Engineered commensals for targeted nose-to-brain drug delivery
2025 Hit
Principles and therapeutic applications of adaptive immunity
2024 Hit
40 intermediate papers

Works of Margot Mütsch being referenced

Use of the Inactivated Intranasal Influenza Vaccine and the Risk of Bell's Palsy in Switzerland
2004 Hit

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Margot Mütsch 476 393 385 370 171 42 1.5k
Gianluca Russo 391 0.8× 267 0.7× 456 1.2× 155 0.4× 258 1.5× 112 1.6k
Paul E. Slater 486 1.0× 203 0.5× 303 0.8× 102 0.3× 107 0.6× 71 1.3k
Marta Heloísa Lopes 1.2k 2.4× 508 1.3× 298 0.8× 146 0.4× 256 1.5× 75 1.6k
Andrew T. Kroger 773 1.6× 179 0.5× 662 1.7× 170 0.5× 113 0.7× 15 1.8k
Margaret Fearon 893 1.9× 499 1.3× 848 2.2× 98 0.3× 241 1.4× 54 1.7k
Charles Vitek 691 1.5× 139 0.4× 682 1.8× 201 0.5× 104 0.6× 41 1.5k
Jonathan Hartzel 831 1.7× 145 0.4× 475 1.2× 144 0.4× 87 0.5× 44 1.8k
John K. Iskander 566 1.2× 175 0.4× 430 1.1× 74 0.2× 108 0.6× 79 1.7k
Leon Heron 1.0k 2.2× 300 0.8× 544 1.4× 100 0.3× 344 2.0× 56 1.7k
Gabriele Poggensee 285 0.6× 328 0.8× 553 1.4× 114 0.3× 104 0.6× 57 1.8k

All Works

Loading papers...

Rankless by CCL
2026